Determination of kFLC and K index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis

Journal of Neuroimmunology

Volumn 263, Issue 1-2, 2013, Pages 116-120

  Duranti, Fabio ^a   Pieri, Massimo ^a   Centonze, Diego ^a   Buttari, Fabio ^a   Bernardini, Sergio ^a   Dessi, Mariarita ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

CSF; KFLC Index; KFLCs; Multiple sclerosis; Nephelometry; OCBs

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; BIOLOGICAL MARKER; IMMUNOGLOBULIN KAPPA CHAIN; OLIGOCLONAL BAND;

ADULT; AGED; ARTICLE; ASSAY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; FOCAL EPILEPSY; HUMAN; IMMUNOGLOBULIN PRODUCTION; K INDEX; KFLC INDEX; LEUKOENCEPHALOPATHY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEOPLASM; NEPHELOMETRIC ASSAY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; BIOSYNTHESIS; BLOOD; CEREBROSPINAL FLUID; IMMUNOLOGY; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; YOUNG ADULT; CENTRAL NERVOUS SYSTEM; CSF/SERUM RATIO OF ALBUMIN; FLC; FREE LIGHT CHAIN; KFLCS; NEPHELOMETRY; OCBS; OLIGOCLONAL IMMUNOGLOBULIN BANDS; Q(ALB);

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CNS; CSF; CSF/SERUM RATIO OF ALBUMIN; FLC; FREE LIGHT CHAIN; IG; IMMUNOGLOBULIN; KFLC INDEX; KFLCS; MS; MULTIPLE SCLEROSIS; NEPHELOMETRY; OCBS; OLIGOCLONAL IMMUNOGLOBULIN BANDS; Q(ALB);

EID: 84884812397     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.07.006     Document Type: Article

References (25)

1. Arneth B., Birklein F. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid. Acta Neurol. Scand. 2009, 119:39-44.
2. Bradwell A.R., Carr-Smith H.D., Mead G.P., Tang L.X., Showell P.J., Drayson M.T., et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin. Chem. 2001, 47:673-680.
3. Caudie C., Allausen O., Bancel J. Detection of oligoclonal IgG bands in cerebrospinal fluid by immunofixation after electrophoretic migration in the automated Hydrasys sebia system. Ann. Biol. Clin. (Paris) 2000, 58:376-379.
4. DeCarli C., Menegus M.A., Rudick R.A. Free light chains in multiple sclerosis and infections of the CNS. Neurology 1987, 37:1334-1338.
5. Desplat-Jego S., Feuillet L., Pelletier J., Bernard D., Cherif A.A., Boucraut J. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry. J. Clin. Immunol. 2005, 25:338-345.
6. Eickhoff K., Heipertz R. Determination of immunoglobulin content of CSF based on light chain characteristics. Ann. Neurol. 1978, 3:509-512.
7. Fagnart O.C., Sindic C.J., Laterre C. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J. Neuroimmunol. 1988, 19:119-132.
8. Fischer C., Arneth B., Koehler J., Lotz J., Lackner K.J. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin. Chem. 2004, 50:1809-1813.
9. Jenkins M.A., Cheng L., Ratnaike S. Multiple sclerosis: use of light-chain typing to assist diagnosis. Ann. Clin. Biochem. 2001, 38:235-241.
10. Krakauer M., Schaldemose Nielsen H., Jensen J., Sellebjerg F. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis. Acta Neurol. Scand. 1998, 98:161-165.
11. Lamers K.J., de Jong J.G., Jongen P.J., Kock-Jansen M.J., Teunesen M.A., Prudon-Rosmulder E.M. Cerebrospinal fluid free kappa light chains versus IgG findings in neurological disorders: qualitative and quantitative measurements. J. Neuroimmunol. 1995, 62:19-25.
12. Laurenzi M.A., Mavra M., Kam-Hansen S., Link H. Oligoclonal IgG and free chains in multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing and immunofixation. Ann. Neurol. 1980, 8:241-247.
13. Luxton R.W., McLean B.N., Thompson E.J. Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. Clin. Chim. Acta 1990, 187:297-308.
14. Mares J., Herzig R., Urbanek K., Sladkova V., Sklenarova J., Bekarek V., et al. Correlation of the IgG index and oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2008, 152:247-249.
15. Mattson D.H., Roos R.P., Hopper J.E., Arnason B.G. Light chain composition of CSF oligoclonal IgG bands in multiple sclerosis and subacute sclerosing panencephalitis. J. Neuroimmunol. 1982, 3:63-76.
16. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
17. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 2001, 310:173-186.
18. Reiber H., Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chim. Acta 1987, 163:319-328.
19. Richard S., Miossec V., Moreau J.F., Taupin J.L. Detection of oligoclonal immunoglobulins in cerebrospinal fluid by an immunofixation-peroxidase method. Clin. Chem. 2002, 48:167-173.
20. Rudick R.A., French C.A., Breton D., Williams G.W. Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests. Neurology 1989, 39:964-968.
21. Rudick R.A., Medendorp S.V., Namey M., Boyle S., Fischer J. Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains. Mult. Scler. 1995, 1:150-155.
22. Rudick R.A., Cookfair D.L., Simonian N.A., Ransohoff R.M., Richert J.R., Jacobs L.D., et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J. Neuroimmunol. 1999, 93:8-14.
23. Sindic C.J., Laterre E.C. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study. J. Neuroimmunol. 1991, 33:63-72.
24. Stanescu G.L., Swick A.R., Tuohy V.K., Rudick R.A. Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid. J. Clin. Lab. Anal. 1991, 5:206-211.
25. Walker R.W., Keir G., Johnson M.H., Thompson E.J. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J. Neuroimmunol. 1983, 4:141-148.